Clinical Trial Update: Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease [NA]

View source ↗

Summary

This clinical trial update describes a study at MD Anderson Cancer Center aimed at optimizing contrast dose and MRI scanning parameters to improve detection of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Disease

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leptomeningeal Disease | NA | Status: NOT_YET_RECRUITING